Skip to content
DataLookout
Menu

NCT05570929

LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Recruiting
  2. Notable Primary completion date: Nov 1, 2024 to Nov 1, 2025
    • Study completion date: Nov 1, 2025 to Nov 1, 2026
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2022 to Feb 7, 2023
    • Secondary endpoints: details revised at 10 of 10 entries
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Fecal microbiome taxonomy (Shannon-Index)
Timeframe: Change from Baseline at 24 weeks

Secondary (10)

Functional capacity of gut microbiota
Frequency of circulating T-cell subtypes
Serum tryptophan metabolites concentration
Serum short-chain fatty acid concentration
Fecal tryptophan metabolites concentration
Show 5 moreShow less
Fecal short-chain fatty acid concentration
Office systolic blood pressure
Office diastolic blood pressure
Body fat content
Fat free mass

Arms and interventions

Kidney Donor

Defined as a human individual donating a kidney

Kidney Recipient

Defined as a patient suffering from chronic kidney disease being the recipient of a kidney transplant

Sites

1 site in 1 country

  • Experimental and Clinical Research CenterBerlin, Germany